AMA
Header D, Ibrahim A, Ramadan A, Dwedar F, Aty K. Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2026;21(1):82-87. doi:10.5114/pg.2026.160534.
APA
Header, D., Ibrahim, A., Ramadan, A., Dwedar, F., & Aty, K. (2026). Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 21(1), 82-87. https://doi.org/10.5114/pg.2026.160534
Chicago
Header, Doaa Abdou, Abeer Mahmoud Ali Ibrahim, Asmaa Mahdy Ramadan, Fatma Ibrahim Dwedar, and Khaled Abdel Aty. 2026. "Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease". Gastroenterology Review/Przegląd Gastroenterologiczny 21 (1): 82-87. doi:10.5114/pg.2026.160534.
Harvard
Header, D., Ibrahim, A., Ramadan, A., Dwedar, F., and Aty, K. (2026). Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 21(1), pp.82-87. https://doi.org/10.5114/pg.2026.160534
MLA
Header, Doaa Abdou et al. "Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 21, no. 1, 2026, pp. 82-87. doi:10.5114/pg.2026.160534.
Vancouver
Header D, Ibrahim A, Ramadan A, Dwedar F, Aty K. Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2026;21(1):82-87. doi:10.5114/pg.2026.160534.